Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2780 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-19 | 2024-05-15 | 225782 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-05 | 2024-05-15 | 224589 |
APO-FINGOLIMOD | 0.5MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-10 | 216744 |
APO-TICAGRELOR | 90MG | TABLET | Actual shortage | 2024-04-12 | 2024-05-10 | 225026 |
APO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-10 | 227088 |
APO-TRIMEBUTINE | 100MG | TABLET | Resolved | 2024-04-19 | 2024-05-10 | 225767 |
APO-OXCARBAZEPINE | 300MG | TABLET | Resolved | 2024-04-05 | 2024-05-10 | 224598 |
APO-OXCARBAZEPINE | 150MG | TABLET | Resolved | 2024-02-09 | 2024-05-10 | 219159 |
APO-COLESEVELAM | 625MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-10 | 216646 |
APO-DOXY CAP 100MG | 100MG | CAPSULE | Actual shortage | 2024-05-10 | 2024-05-10 | 227728 |
APO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-10 | 227725 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-10 | 227722 |
APO-OLMESARTAN | 20MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-10 | 216711 |
APO-SITAGLIPTIN MALATE | 25MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-10 | 227717 |
APO-VALACYCLOVIR | 1000MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-10 | 227714 |
APO-VALACYCLOVIR | 500MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-10 | 227031 |
APO-LEFLUNOMIDE | 20MG | TABLET | Actual shortage | 2024-04-26 | 2024-05-10 | 226315 |
APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-05-10 | 225779 |
APO-DASATINIB | 70MG | TABLET | Actual shortage | 2024-04-19 | 2024-05-10 | 225776 |
APO-TERBINAFINE | 250MG | TABLET | Actual shortage | 2024-04-12 | 2024-05-10 | 225005 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OLANZAPINE | 10.0MG | TABLET | Discontinued | 2018-09-08 | 2018-12-18 | 60672 |
APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-NITRAZEPAM | 10MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1117 |
APO-NITRAZEPAM | 5MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1110 |
APO-ENALAPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-12-05 | 60462 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
APO-ENALAPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-19 | 60465 |
APO-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-11-16 | 60474 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
APO-ENALAPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60468 |
APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | To be discontinued | 2018-09-07 | 2018-11-02 | 60423 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |